Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (111-120 of 349) with videos related to

Pageof 35
Sort By:
Urology|November 20, 2003
Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancerMasood A Khan, Alan W Partin, Leslie A Mangold, et al.
The Journal of Urology|January 25, 2003
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancerMisop Han, Alan W Partin, Marianna Zahurak, et al.
Cancer|February 23, 2007
Radical prostatectomy for clinical stage T3a diseaseStephen J Freedland, Alan W Partin, Elizabeth B Humphreys, et al.
The Urologic Clinics of North America|November 29, 2015
Urinary Biomarkers for Prostate CancerJeffrey J Tosoian, Ashley E Ross, Lori J Sokoll, et al.
The Prostate|May 7, 2008
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shapeSumit Isharwal, Michael C Miller, Cameron Marlow, et al.
BJU International|July 9, 2011
Obesity and prostate enlargement in men with localized prostate cancerRyan P Kopp, Misop Han, Alan W Partin, et al.
The Prostate|May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
BJU International|July 30, 2016
Role of biobanking in urology: a reviewHeather J Chalfin, Elizabeth Fabian, Leslie Mangold, et al.
BJU International|March 24, 2007
Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomyJ Kellogg Parsons, Alan W Partin, Bruce Trock, et al.
The Journal of Urology|November 17, 2009
The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warrantedPhillip M Pierorazio, Jonathan I Epstein, Elizabeth Humphreys, et al.
Pageof 35

Showing results (111-120 of 349) with videos related to

Sort By:
Pageof 35
Urology|November 20, 2003
Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancerMasood A Khan, Alan W Partin, Leslie A Mangold, et al.
The Journal of Urology|January 25, 2003
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancerMisop Han, Alan W Partin, Marianna Zahurak, et al.
Cancer|February 23, 2007
Radical prostatectomy for clinical stage T3a diseaseStephen J Freedland, Alan W Partin, Elizabeth B Humphreys, et al.
The Urologic Clinics of North America|November 29, 2015
Urinary Biomarkers for Prostate CancerJeffrey J Tosoian, Ashley E Ross, Lori J Sokoll, et al.
The Prostate|May 7, 2008
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shapeSumit Isharwal, Michael C Miller, Cameron Marlow, et al.
BJU International|July 9, 2011
Obesity and prostate enlargement in men with localized prostate cancerRyan P Kopp, Misop Han, Alan W Partin, et al.
The Prostate|May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
BJU International|July 30, 2016
Role of biobanking in urology: a reviewHeather J Chalfin, Elizabeth Fabian, Leslie Mangold, et al.
BJU International|March 24, 2007
Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomyJ Kellogg Parsons, Alan W Partin, Bruce Trock, et al.
The Journal of Urology|November 17, 2009
The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warrantedPhillip M Pierorazio, Jonathan I Epstein, Elizabeth Humphreys, et al.
Pageof 35